Didier Coquoz
Copexis, Switzerland
Title: Are we at the start of a new era for anti-microbial and anti-cancers therapies?
Biography
Biography: Didier Coquoz
Abstract
Didier Coquoz has completed his PhD in Clinical Pharmacology. He has more than 20 years of experience as Pharma R&D Executive (VP R&D and CEO). He has been instrumental in the development/regulatory management from drug candidate up to phase III and registration of close to 30 biologics, monoclonal antibodies, peptides, cell-based therapeutics, NCEs of which 4 reached the market world-wide. He held positions as CEO and VP R&D on both sides of the Atlantic. He currently acts through Copexis S.A. as Chief Development Officer, Chief Regulatory Affairs and Chief Business Development Affairs for different biotechs/mid pharma in Europe, mostly in immunology.
Speaker Presentations
Speaker PPTs Click Here